2018-2023 Philippines Capecitabine Market Report (Status and Outlook)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 87

In 2017, the Capecitabine market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In Philippines market, the top players include

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Split by product types/category, covering

- 500 mg

- 150 mg

Split by applications/end use industries, covers

- Breast Cancer

- Colorectal cancer

- Stomach Cancer

2018-2023 Philippines Capecitabine Market Report (Status and Outlook)

Table of Contents

2018-2023 Philippines Capecitabine Market Report (Status and Outlook)
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Market Segment by Types
1.2.1 Philippines Capecitabine Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 Philippines Capecitabine Sales Market Share by Types in 2017
1.2.3 500 mg
1.2.3.1 Major Players of 500 mg
1.2.4 150 mg
1.2.4.1 Major Players of 150 mg
1.3 Philippines Capecitabine Market Segment by Applications/End Use Industries
1.3.1 Philippines Capecitabine Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 Philippines Capecitabine Sales Market Share by Applications in 2017
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 Philippines Capecitabine Overview and Market Size (Value) (2013-2023)
1.4.1 Philippines Market Capecitabine Overview
1.4.2 Philippines Capecitabine Market Size (Value and Volume) Status and Forecast (2013-2023)
2 Philippines Capecitabine Sales, Revenue (Value) and Market Share by Players
2.1 Philippines Capecitabine Sales and Market Share by Players (2013-2018)
2.2 Philippines Capecitabine Revenue and Market Share by Players (2013-2018)
2.3 Philippines Capecitabine Average Price by Players in 2017
2.4 Philippines Capecitabine Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Capecitabine Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 Philippines Capecitabine Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 Philippines Capecitabine Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 Philippines Capecitabine Sales and Market Share by Type (2013-2018)
3.1.2 Philippines Capecitabine Revenue and Market Share by Type (2013-2018)
3.1.3 Philippines Capecitabine Price by Type (2013-2018)
3.2 Philippines Capecitabine Sales and Market Share by Application (2013-2018)
3.3 Philippines Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 Philippines Capecitabine Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Capecitabine Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Teva
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Capecitabine Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Teva News
4.3 Mylan
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Capecitabine Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Mylan News
4.4 Hikma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Capecitabine Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Hikma News
4.5 Hengrui Medicine
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Capecitabine Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Hengrui Medicine News
4.6 Cipla
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Capecitabine Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Cipla News
4.7 Reliance Group
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Capecitabine Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Reliance Group News
4.8 Hetero
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Capecitabine Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Hetero News
5 Philippines Capecitabine Market Forecast (2018-2023)
5.1 Philippines Capecitabine Sales, Revenue and Price Forecast (2018-2023)
5.1.1 Philippines Capecitabine Sales and Growth Rate Forecast (2018-2023)
5.1.2 Philippines Capecitabine Revenue and Growth Rate Forecast (2018-2023)
5.1.3 Philippines Capecitabine Price Trend Forecast (2018-2023)
5.2 Philippines Capecitabine Sales Forecast by Type (2018-2023)
5.3 Philippines Capecitabine Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Capecitabine
6.1 Main Raw Materials of Capecitabine
6.1.1 List of Capecitabine Main Raw Materials
6.1.2 Capecitabine Main Raw Materials Price Analysis
6.1.3 Capecitabine Raw Materials Major Suppliers
6.1.4 Capecitabine Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Capecitabine
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Capecitabine Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Capecitabine Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Capecitabine Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Capecitabine Distributors/Traders List in Philippines
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Capecitabine
Table Product Specifications of Capecitabine
Figure Philippines Capecitabine Sales (volume) for Each Type (2013-2023)
Figure Philippines Capecitabine Sales Market Share by Types in 2017
Table Types of Capecitabine
Figure Product Picture of 500 mg
Table Major Players of 500 mg
Figure Product Picture of 150 mg
Table Major Players of 150 mg
Figure Philippines Capecitabine Sales Present Situation and Outlook by Applications (2013-2023)
Figure Philippines Capecitabine Sales Market Share by Applications in 2017
Table Applications of Capecitabine
Figure Breast Cancer Examples
Figure Colorectal cancer Examples
Figure Stomach Cancer Examples
Figure Philippines Capecitabine Revenue (Million USD) Status and Forecast (2013-2023)
Figure Philippines Capecitabine Sales (Volume) Status and Forecast (2013-2023)
Table Philippines Capecitabine Sales by Players (2013-2018)
Table Philippines Capecitabine Sales Market Share (%) by Players (2013-2018)
Figure Philippines Capecitabine Sales Market Share by Players in 2016
Figure Philippines Capecitabine Sales Market Share by Players in 2017
Table Philippines Capecitabine Revenue (Million USD) by Players (2013-2018)
Table Philippines Capecitabine Revenue Market Share (%) by Players (2013-2018)
Figure Philippines Capecitabine Revenue Market Share by Players in 2016
Figure Philippines Capecitabine Revenue Market Share by Players in 2017
Figure Philippines Capecitabine Average Price by Players in 2017
Table Philippines Capecitabine Manufacturing Base Distribution and Sales Area by Players
Table Players Capecitabine Product Types
Figure Capecitabine Market Share of Top 3 Players in 2017
Figure Capecitabine Market Share of Top 5 Players in 2017
Table Philippines Capecitabine Sales by Type (2013-2018)
Table Philippines Capecitabine Sales Market Share by Type (2013-2018)
Figure Philippines Capecitabine Sales Market Share by Type in 2013
Figure Philippines Capecitabine Sales Market Share by Type in 2017
Table Philippines Capecitabine Revenue (Million USD) by Type (2013-2018)
Table Philippines Capecitabine Revenue Market Share by Type (2013-2018)
Figure Philippines Capecitabine Revenue Market Share by Type in 2013
Figure Philippines Capecitabine Revenue Market Share by Type in 2017
Table Philippines Capecitabine Price by Type (2013-2018)
Table Philippines Capecitabine Sales by Application (2013-2018)
Table Philippines Capecitabine Sales Market Share by Application (2013-2018)
Figure Philippines Capecitabine Sales Market Share by Application (2013-2018)
Figure Philippines Capecitabine Sales Market Share by Application in 2017
Table Philippines Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Capecitabine Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Capecitabine Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Capecitabine Market Share (2012-2017)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hikma Capecitabine Market Share (2012-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hengrui Medicine Capecitabine Market Share (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Capecitabine Market Share (2012-2017)
Table Reliance Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Market Share (2012-2017)
Table Hetero Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Capecitabine Market Share (2012-2017)
Figure Philippines Capecitabine Sales and Growth Rate Forecast (2018-2023)
Figure Philippines Capecitabine Revenue and Growth Rate Forecast (2018-2023)
Figure Philippines Capecitabine Price Trend Forecast (2018-2023)
Table Philippines Capecitabine Sales Forecast by Type (2018-2023)
Figure Philippines Capecitabine Sales Market Share Forecast by Type (2018-2023)
Figure Philippines Capecitabine Sales Market Share Forecast by Type in 2023
Table Philippines Capecitabine Sales Forecast by Application (2018-2023)
Figure Philippines Capecitabine Sales Market Share Forecast by Application (2018-2023)
Figure Philippines Capecitabine Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Capecitabine Main Raw Materials Price Trend
Table Capecitabine Raw Materials Major Suppliers List
Figure Production Cost Structure of Capecitabine
Figure Capecitabine Manufacturing Process/Method
Figure Capecitabine Value Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players in 2017
Table Major Buyers of Capecitabine
Table Capecitabine Distributors/Traders List in Philippines
  • Erlotinib Hydrochloride Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 23-Jun-2019        Price: US 2280 Onwards        Pages: 88
    According to 99Strategy, the Global Erlotinib Hydrochloride Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Erlotinib Hydrochloride market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the fac......
  • Global Fluorouracil Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 21-Jun-2019        Price: US 2900 Onwards        Pages: 196
    The Fluorouracil market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Fluorouracil. Global Fluorouracil industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and grow......
  • Global Cancer Targeted Therapy Market Size, Status and Forecast 2019-2025
    Published: 21-Jun-2019        Price: US 3900 Onwards        Pages: 112
    In 2018, the global Cancer Targeted Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Cancer Targeted Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Targeted Therapy development in United States, Europe and China. The key players covered in this study - Advaxis ......
  • Global Prostate Cancer Market Research Report 2012-2024
    Published: 20-Jun-2019        Price: US 1800 Onwards        Pages: 68
    Summary The global Prostate Cancer market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as foll......
  • Global DNA Repair Drugs Market Insights, Forecast to 2025
    Published: 19-Jun-2019        Price: US 3900 Onwards        Pages: 122
    DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body's innate DNA repair mechanism and aid in the treatme......
  • Global Kidney Cancer Drugs Market Insights, Forecast to 2025
    Published: 19-Jun-2019        Price: US 3900 Onwards        Pages: 145
    Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ......
  • Global 5-Fluorouracil Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Jun-2019        Price: US 3480 Onwards        Pages: 115
    5-fluorouracil is being studied in the treatment of other conditions and types of cancer. It stops cells from making DNA and may kill cancer cells. The statistic scope is 5-Fluorouracil API in this report. Scope of the Report: The worldwide market for 5-Fluorouracil is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focu......
  • Hematological Malignancies Disease Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
    Published: 17-Jun-2019        Price: US 2280 Onwards        Pages: 80
    According to 99Strategy, the Global Hematological Malignancies Disease Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Hematological Malignancies Disease market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the r......
  • Kidney Cancer Drugs Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 17-Jun-2019        Price: US 3000 Onwards        Pages: 138
    Kidney Cancer Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Kidney Cancer Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Kidney Cancer Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Kidney......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs